| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.796 | 0.004 | 0.796 | Cardiotonic | 0.709 0.005 DBMET00363 | ||
| 0.778 | 0.004 | 0.778 | Spasmolytic | 0.572 0.016 DBMET00363 | ||
| 0.701 | 0.005 | 0.701 | Potassium channel (Voltage-sensitive) blocker | 0.454 0.019 DBMET00363 | ||
| 0.674 | 0.005 | 0.674 | Hypoglycemic | 0.652 0.006 DBMET00363 | ||
| 0.664 | 0.011 | 0.664 | Toll-Like receptor agonist | 0.209 0.191 DBMET00363 | ||
| 0.656 | 0.005 | 0.656 | HERG channel blocker | 0.396 0.028 DBMET00363 | ||
| 0.661 | 0.011 | 0.661 | Toll-Like receptor 7 agonist | 0.209 0.191 DBMET00363 | ||
| 0.589 | 0.006 | 0.589 | Vasodilator | 0.552 0.008 DBMET00363 | ||
| 0.573 | 0.004 | 0.573 | Cholinergic antagonist | 0.221 0.027 DBMET00363 | ||
| 0.568 | 0.004 | 0.568 | Acetylcholine antagonist | 0.213 0.028 DBMET00363 | ||
| 0.568 | 0.007 | 0.573 | Potassium channel blocker | 0.573 0.006 DBMET00363 | DBMET00363 | |
| 0.483 | 0.004 | 0.483 | Acetylcholine M1 receptor antagonist | 0.241 0.028 DBMET00363 | ||
| 0.473 | 0.004 | 0.473 | Acetylcholine muscarinic antagonist | 0.19 0.027 DBMET00363 | ||
| 0.343 | 0.004 | 0.343 | Uric acid excretion stimulant | 0.304 0.005 DBMET00363 | ||
| 0.394 | 0.094 | 0.407 | Cyclophilin D inhibitor | 0.407 0.087 DBMET00363 | DBMET00363 | |
| 0.291 | 0.054 | 0.326 | Superoxide dismutase inhibitor | 0.326 0.042 DBMET00363 | DBMET00363 | |
| 0.24 | 0.005 | 0.24 | Thioredoxin inhibitor | 0.232 0.005 DBMET00363 | ||
| 0.288 | 0.054 | 0.288 | Ca(v)3.3 blocker | 0.277 0.065 DBMET00363 | ||
| 0.247 | 0.019 | 0.247 | Sodium channel blocker | 0.115 0.091 DBMET00363 | ||
| 0.32 | 0.118 | 0.32 | 15-Lipoxygenase inhibitor | |||
| 0.334 | 0.17 | 0.334 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.265 0.263 DBMET00363 | ||
| 0.242 | 0.089 | 0.242 | 5 Hydroxytryptamine uptake stimulant | 0.234 0.099 DBMET00363 | ||
| 0.187 | 0.036 | 0.187 | Anesthetic local | |||
| 0.155 | 0.011 | 0.155 | Acetylcholine M3 receptor antagonist | |||
| 0.244 | 0.102 | 0.244 | Insulysin inhibitor | 0.222 0.126 DBMET00363 | ||
| 0.159 | 0.019 | 0.159 | Porphobilinogen synthase inhibitor | 0.065 0.061 DBMET00363 | ||
| 0.151 | 0.011 | 0.151 | Acetylcholine M2 receptor antagonist | |||
| 0.198 | 0.065 | 0.198 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.147 | 0.018 | 0.147 | Acetylcholine release stimulant | |||
| 0.13 | 0.019 | 0.13 | Analgesic, opioid | 0.082 0.045 DBMET00363 | ||
| 0.118 | 0.013 | 0.118 | Acetylcholine M5 receptor antagonist | |||
| 0.151 | 0.053 | 0.151 | Nav1.6 sodium channel blocker | |||
| 0.108 | 0.022 | 0.108 | Thioredoxin reductase inhibitor | 0.088 0.045 DBMET00363 | ||
| 0.202 | 0.116 | 0.202 | Neuropeptide Y2 antagonist | 0.199 0.121 DBMET00363 | ||
| 0.277 | 0.192 | 0.348 | 5 Hydroxytryptamine release inhibitor | 0.348 0.117 DBMET00363 | DBMET00363 | |
| 0.108 | 0.023 | 0.108 | Acetylcholine M4 receptor antagonist | |||
| 0.213 | 0.129 | 0.216 | Gastrin inhibitor | 0.216 0.125 DBMET00363 | DBMET00363 | |
| 0.22 | 0.145 | 0.22 | Thyroid hormone antagonist | |||
| 0.099 | 0.028 | 0.099 | Aminopeptidase I inhibitor | 0.082 0.04 DBMET00363 | ||
| 0.155 | 0.089 | 0.155 | Antipruritic | 0.143 0.102 DBMET00363 | ||
| 0.105 | 0.042 | 0.105 | Histamine N-methyltransferase inhibitor | |||
| 0.162 | 0.106 | 0.242 | Psychostimulant | 0.242 0.061 DBMET00363 | DBMET00363 | |
| 0.182 | 0.126 | 0.214 | Peptidyltransferase inhibitor | 0.214 0.083 DBMET00363 | DBMET00363 | |
| 0.095 | 0.042 | 0.095 | Hematopoietic | 0.09 0.049 DBMET00363 | ||
| 0.186 | 0.134 | 0.294 | 5 Hydroxytryptamine release stimulant | 0.294 0.072 DBMET00363 | DBMET00363 | |
| 0.144 | 0.092 | 0.144 | Growth hormone agonist | 0.131 0.106 DBMET00363 | ||
| 0.123 | 0.071 | 0.123 | Nav1.3 sodium channel blocker | 0.112 0.083 DBMET00363 | ||
| 0.09 | 0.041 | 0.116 | Somatostatin 1 agonist | 0.116 0.025 DBMET00363 | DBMET00363 | |
| 0.091 | 0.045 | 0.091 | Acetylcholine nicotinic antagonist | |||
| 0.058 | 0.015 | 0.063 | Histamine H2 receptor agonist | 0.063 0.013 DBMET00363 | DBMET00363 | |
| 0.055 | 0.013 | 0.062 | Histamine H1 receptor agonist | 0.062 0.007 DBMET00363 | DBMET00363 | |
| 0.054 | 0.017 | 0.054 | GHS receptor agonist | |||
| 0.195 | 0.158 | 0.195 | Thyroid hormone beta antagonist | |||
| 0.068 | 0.031 | 0.068 | Histone deacetylase SIRT3 inhibitor | |||
| 0.19 | 0.155 | 0.19 | MAP kinase kinase 3 inhibitor | |||
| 0.064 | 0.037 | 0.064 | Bombesin 1 receptor agonist | |||
| 0.046 | 0.019 | 0.046 | Factor XIIIa inhibitor | |||
| 0.046 | 0.022 | 0.046 | Plasmepsin II inhibitor | |||
| 0.082 | 0.06 | 0.082 | Histamine H2 receptor antagonist | 0.082 0.061 DBMET00363 | ||
| 0.052 | 0.035 | 0.052 | Vanilloid 2 antagonist | |||
| 0.108 | 0.093 | 0.108 | Cathepsin H inhibitor | 0.105 0.098 DBMET00363 | ||
| 0.054 | 0.04 | 0.054 | Immunoglobulin Fc receptor antagonist | |||
| 0.084 | 0.071 | 0.084 | Antihistaminic | |||
| 0.071 | 0.058 | 0.074 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.074 0.05 DBMET00363 | DBMET00363 | |
| 0.034 | 0.022 | 0.034 | Growth hormone releasing factor agonist | |||
| 0.055 | 0.046 | 0.068 | Botulinum neurotoxin type A inhibitor | 0.068 0.028 DBMET00363 | DBMET00363 | |
| 0.084 | 0.078 | 0.129 | Aminopeptidase B inhibitor | 0.129 0.048 DBMET00363 | DBMET00363 | |
| 0.015 | 0.008 | 0.015 | 5 Lipoxygenase activating protein inhibitor | |||
| 0.056 | 0.05 | 0.056 | Potassium channel (Ca-activated) blocker | |||
| 0.058 | 0.052 | 0.058 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.075 | 0.07 | 0.075 | Histamine antagonist | |||
| 0.047 | 0.043 | 0.048 | Ribonucleoside-diphosphate reductase inhibitor | 0.048 0.042 DBMET00363 | DBMET00363 | |
| 0.053 | 0.05 | 0.055 | Carbonic anhydrase stimulant | 0.055 0.046 DBMET00363 | DBMET00363 | |
| 0.047 | 0.044 | 0.047 | Ribonucleotide reductase inhibitor | 0.047 0.044 DBMET00363 | ||
| 0.092 | 0.092 | 0.133 | Factor V inhibitor | 0.133 0.028 DBMET00363 | DBMET00363 | |
| 0.003 | 0.005 | 0.005 | Reverse transcriptase (HBV) inhibitor | 0.005 0.003 DBMET00363 | DBMET00363 | |
| 0.049 | 0.053 | 0.071 | CXC chemokine 4 receptor antagonist | 0.071 0.036 DBMET00363 | DBMET00363 | |
| 0.033 | 0.054 | 0.055 | Geranyltranstransferase inhibitor | 0.055 0.017 DBMET00363 | DBMET00363 | |
| 0.039 | 0.064 | 0.059 | Histamine agonist | 0.059 0.029 DBMET00363 | DBMET00363 | |
| 0.114 | 0.139 | 0.15 | Adenylate cyclase stimulant | 0.15 0.063 DBMET00363 | DBMET00363 | |
| 0.121 | 0.172 | 0.171 | Aldehyde oxidase inhibitor | 0.171 0.122 DBMET00363 | DBMET00363 | |
| 0.076 | 0.127 | 0.094 | Nav1.4 sodium channel blocker | 0.094 0.085 DBMET00363 | DBMET00363 | |
| 0.029 | 0.087 | 0.05 | Beta 2 adrenoreceptor antagonist | 0.05 0.036 DBMET00363 | DBMET00363 | |
| 0.123 | 0.187 | 0.163 | Neurotensin receptor agonist | 0.163 0.074 DBMET00363 | DBMET00363 | |
| 0.032 | 0.102 | 0.08 | Myc inhibitor | 0.08 0.013 DBMET00363 | DBMET00363 | |
| 0.013 | 0.084 | 0.039 | Complement C3a chemotactic receptor antagonist | 0.039 0.033 DBMET00363 | DBMET00363 | |
| 0.041 | 0.129 | 0.07 | Thrombin inhibitor | 0.07 0.055 DBMET00363 | DBMET00363 | |
| 0.147 | 0.246 | 0.213 | Vasodilator, coronary | 0.213 0.17 DBMET00363 | DBMET00363 | |
| 0.152 | 0.292 | 0.252 | Interleukin 2 agonist | 0.252 0.116 DBMET00363 | DBMET00363 | |
| 0.157 | 0.334 | 0.195 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.195 0.181 DBMET00363 | DBMET00363 | |
| 0.06 | 0.261 | 0.096 | Folate antagonist | 0.096 0.072 DBMET00363 | DBMET00363 | |
| 0.123 | 0.325 | 0.323 | Sodium/bile acid cotransporter inhibitor | 0.323 0.059 DBMET00363 | DBMET00363 | |
| 0.125 | 0.41 | 0.335 | Apoptosis agonist | 0.335 0.149 DBMET00363 | DBMET00363 | |
| 0.038 | 0.367 | 0.126 | Anticoagulant | 0.126 0.105 DBMET00363 | DBMET00363 | |
| 0.03 | 0.363 | 0.139 | Thrombolytic | 0.139 0.091 DBMET00363 | DBMET00363 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |